Cerebral oxygenation monitoring in critical care patients with traumatic brain injury

T Tokutomi,M Shigemori,T Miyagi,H Katsuki,Y Takeuchi

doi:10.1186/cc7259

T Tokutomi, M Shigemori + Show 3 more

Open Access

PDF Available

https://doi.org/10.1186/cc7259

Copy DOI

Export

Save

Cite

Journal: Critical Care	Publication Date: Jan 1, 2009
License type: cc-by

Affiliation: Kurume University

Abstract
Highlights/Summary
Full-Text PDF
Similar Papers

Abstract

Listen

One of the most controversial areas of traumatic brain injury (TBI) critical care is the management of cerebral perfusion pressure (CPP). Since optimal CPP levels depend on whether cerebral autoregulation is preserved, these levels must be determined for individual cases. The aim of this study was to investigate the role of jugular venous saturation (SjO2) and brain tissue oxygen tension (PbrO2) monitoring in addition to CPP and intracranial pressure (ICP) monitoring in the acute management of patients with TBI.

Highlights

There is considerable uncertainty about the reproducibility of the various instruments used to measure dyspnea, their ability to reflect changes in symptoms, whether they accurately reflect the patient’s experience and if its evolution is similar between acute heart failure syndrome patients and nonacute heart failure syndrome patients
There were no significant differences in the total length of pediatric ICU (PICU) stay or mortality odds ratios (0.94, 95% cardiac index (CI) = 0.33 to 2.54)
Results of this study show that early tracheostomy, if perioperative complications

Summary

Introduction

There is considerable uncertainty about the reproducibility of the various instruments used to measure dyspnea, their ability to reflect changes in symptoms, whether they accurately reflect the patient’s experience and if its evolution is similar between acute heart failure syndrome patients and nonacute heart failure syndrome patients. Conclusions Our data demonstrate that critically ill patients may be exposed to a higher FiO2 than that required to maintain adequate oxygenation These results highlight an area of ICU care that has received little study, with no published clinical trials examining the effect of FiO2 on outcome. Results Age, sex, the underlying disease and tumour stage (TNM classification), type of previous anticancer treatment, performance status, severity scores (APACHE II, Simplified Acute Physiology Score II, Sequential Organ Failure Assessment), ICU and hospital mortalities and hospital outcome at 3, 6 and 12 months were analysed. Clinical data of 277 post-transplantation patients admitted to the ICU were collected at admission and the SAPS 3 and APACHE II score calculated with respective estimated mortality rates.

Objectives

Methods

Results

Conclusion